We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.19 | 2.97% | 6.59 | 6.20 | 6.98 | - | 196,136 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.73 | 12.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/3/2020 21:51 | Well AZ or whoever signs a deal with SNG will probably sign a global deal. Why would they restrict themselves to Europe or even the US. That is why it is likely to be an absolute mega deal; the queue of companies will be out the door so it is most definitely a seller's market! | nobbygnome | |
24/3/2020 21:43 | NobbyIt seems almost immoral to mention it ...but how long do you think it will take to strike all the deals required to treat those affected around the world.Surely the disease has to eradicated globally before the world economy can get back to some sort of normality. | kop202 | |
24/3/2020 21:23 | About 2.5% of the shares in circulation turned up as LRGS trades. Interesting given price action end of the day. | talk2dubya | |
24/3/2020 20:47 | https://www.thailand | ic0gcds00 | |
24/3/2020 20:16 | good link Applepieinthesky This is also interesting (but sadly not for Mr. Li)… hxxps://www.thailand | fez | |
24/3/2020 19:39 | https://www.thailand | applepieinthesky | |
24/3/2020 16:47 | Festario .. 🙄 | exter | |
24/3/2020 16:46 | PS 2 months is a bit of a guesstimate because no process is the same. | nobbygnome | |
24/3/2020 16:42 | >> fez Excellent question and is the main conundrum as far as I am concerned. From my knowledge of making protein drugs, it will take about 2 months to ferment, purify and release a batch of drug. So the question is are they going to do that at risk ahead of the result because as I have said before I expect approval on the back of the first trial if the results are good. I suspect that is where someone like AZ or Merck will come in.... | nobbygnome | |
24/3/2020 16:37 | 54.2 close. | tidy 2 | |
24/3/2020 16:37 | That chart looks fantastic! Tomorrow and Friday will be very special. | likya123 | |
24/3/2020 16:34 | Question for Nobbygnome (or anyone else with knowledge of the field) Assuming SNG001 treatment proves effective...how quickly can production of the formulation be ramped up? | fez | |
24/3/2020 16:33 | And a good strong finish bodes well for tomorrow morning and onwards. | nobbygnome | |
24/3/2020 16:32 | AZ is the most likely source of finance, although I don't rule out a small fundraising. And I stress again the latter will not be a problem especially with the current volume. Another 8% plus was traded today. Whatever happens SNG are in a fantastic position to drive a hard bargain particularly with a Pharma. There will be a queue out the door to collaborate and so they should be able to pick and choose. | nobbygnome | |
24/3/2020 16:28 | Or AZN cough up | tidy 2 | |
24/3/2020 16:27 | Scandal....Spains Granny-farmgate | kop202 | |
24/3/2020 16:26 | tickboo, saw89, I do actually agree a Government grant is a very likely possibility for SNG | bountyhunter | |
24/3/2020 16:26 | A juicy government grant is another potential catalyst here | saw89 | |
24/3/2020 16:24 | I only posted that in response to dave444's deliberately disruptive post on my NCYT thread, so you push off Dave or I will continue to retaliate here which I would rather not do! | bountyhunter | |
24/3/2020 16:24 | I'm pretty sure government grants will be available especially for SNG. Can't see a placing here at all and if there was it could be for a premium. | tickboo | |
24/3/2020 16:23 | placing fears? | bountyhunter | |
24/3/2020 16:22 | SNG has 8 bagged for me so far | toffeeman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions